Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
101.00    9.60 (10.50%)
Bid:
100.80
Ask:
101.40
Spread: 0.60 (0.595%)
Market Cap: £424.56m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

TRADING UPDATE

Today 07:00

RNS Number : 5558I
PZ CUSSONS PLC
17 June 2026
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

17 June 2026

TRADING UPDATE

Continued strong trading

Upgrade to FY26 profit guidance

 

PZ Cussons plc ("PZ Cussons" or "the Group") today issues a trading update for the year ended 31 May 2026.

 

The Group expects to report like for like revenue growth of c.6% for FY26, with reported revenue of c.£540 million. Performance continues to be broad-based, with growth across each of our four lead markets.

 

Reflecting continued strong trading and ongoing stability in the Nigerian Naira, the Group now expects to report FY26 adjusted Operating Profit at, or slightly above, the upper end of the previously guided range of £53-57 million. This compares to an initial guidance range of £48-53 million provided at the start of the financial year.

 

Net debt is expected to be less than £30 million[1]. This represents a reduction of over £80 million compared to FY25, driven primarily by the sale of the 50% stake in the PZ Wilmar joint venture. In addition, the financial guardrails which management are embedding to mitigate volatility in Nigeria have continued to reduce the Group's sensitivity to future movements in the Naira.

 

Looking ahead to FY27, the Group is mindful of the potential impact of the conflict in the Middle East and has already taken actions which are expected to offset a large majority of any cost inflation.

 

The Group will report FY26 results on 6 August 2026.

Contact details

 

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Charlie Twigg

About PZ Cussons

 

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK, employing 2,000 people internationally. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. We are focused on our lead markets of the UK, ANZ, Nigeria and Indonesia across the core categories of Personal, Home and Baby Care. Our locally-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa, Stella and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are core to what we do and captured by our purpose: For Everyone. For Life. For Good.

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward-looking statements contained within this announcement.


[1] Including cash held in Nigeria. Further detail on the breakdown of cash will be provided as part of the full year results announcement

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUAUQUPQGMQ
Date   Source Headline
21st Nov 20247:00 amRNSAGM Trading Statement
20th Nov 20241:36 pmRNSDirector/PDMR Shareholding
21st Oct 20249:21 amRNSDirector/PDMR Shareholding
27th Sep 20241:16 pmRNSDirector/PDMR Shareholding
27th Sep 20241:11 pmRNSDirector/PDMR Shareholding
26th Sep 20244:09 pmRNSPublication of Annual Report and Notice of AGM
25th Sep 20245:48 pmRNSDirector/PDMR Shareholding
25th Sep 202410:40 amRNSDirector Declaration
19th Sep 20245:36 pmRNSDirector/PDMR Shareholding
18th Sep 20247:22 amRNSBoard Change
21st Aug 20244:29 pmRNSDirector/PDMR Shareholding
25th Jul 202411:10 amRNSDirector/PDMR Shareholding
19th Jul 20245:31 pmRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSTrading Statement
25th Jun 20249:39 amRNSDirector/PDMR Shareholding
20th May 202411:52 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNS2023 AGM Voting Results Update Statement
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.